p16Ink4a+ cancer-associated fibroblasts

Biomarker

1 paper1 finding

  • Animals1

Interventions

1

XL888

downin mice1

1 study
  1. XL888 decreases p16Ink4a+ cancer-associated fibroblasts in mice.

    “XL888, an HSP90 inhibitor, that clears p16Ink4a+ cancer-associated fibroblasts in vivo.”

    Animalsadvanced LUAD

    Senolytic-sensitive p16Ink4a+ fibroblasts in the tumor stroma rewire lung cancer metabolism and plasticity

    Cell stem cell3 Nov 2025

More on XL888

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months